{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:53:27Z","timestamp":1790924007877,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"DOI":"10.1038\/s41433-026-04534-w","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:32:48Z","timestamp":1790875968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of 0.01% atropine in Chinese children with nearwork-induced transient myopia: a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1038","author":[{"given":"Yunwei","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaguang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0350-4071","authenticated-orcid":false,"given":"Man","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"4534_CR1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jama.2015.10803","volume":"314","author":"M He","year":"2015","unstructured":"He M, Xiang F, Zeng Y, Mai J, Chen Q, Zhang J, et al. Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial. JAMA. 2015;314:1142\u20138.","journal-title":"JAMA"},{"key":"4534_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036\u201342.","journal-title":"Ophthalmology"},{"key":"4534_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/aos.12387","volume":"92","author":"O Parssinen","year":"2014","unstructured":"Parssinen O, Kauppinen M, Viljanen A. The progression of myopia from its onset at age 8-12 to adulthood and the influence of heredity and external factors on myopic progression. A 23-year follow-up study. Acta Ophthalmol. 2014;92:730\u20139.","journal-title":"Acta Ophthalmol"},{"key":"4534_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/ICL.0000000000000499","volume":"44","author":"J Cooper","year":"2018","unstructured":"Cooper J, Tkatchenko AV. A review of current concepts of the etiology and treatment of myopia. Eye Contact Lens. 2018;44:231\u201347.","journal-title":"Eye Contact Lens"},{"key":"4534_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ophtha.2015.07.002","volume":"123","author":"L Shen","year":"2016","unstructured":"Shen L, Melles RB, Metlapally R, Barcellos L, Schaefer C, Risch N, et al. The association of refractive error with glaucoma in a multiethnic population. Ophthalmology. 2016;123:92\u2013101.","journal-title":"Ophthalmology"},{"key":"4534_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41572-020-00231-4","volume":"6","author":"PN Baird","year":"2020","unstructured":"Baird PN, Saw SM, Lanca C, Guggenheim JA, Smith Iii EL, Zhou X, et al. Myopia. Nat Rev Dis Prim. 2020;6:99.","journal-title":"Nat Rev Dis Prim"},{"key":"4534_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF01204624","volume":"91","author":"E Ong","year":"1995","unstructured":"Ong E, Ciuffreda KJ. Nearwork-induced transient myopia: a critical review. Doc Ophthalmol. 1995;91:57\u201385.","journal-title":"Doc Ophthalmol"},{"key":"4534_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1475-1313.2008.00550.x","volume":"28","author":"KJ Ciuffreda","year":"2008","unstructured":"Ciuffreda KJ, Vasudevan B. Nearwork-induced transient myopia (NITM) and permanent myopia-is there a link? Ophthalmic Physiol Opt. 2008;28:103\u201314.","journal-title":"Ophthalmic Physiol Opt"},{"key":"4534_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.optom.2020.05.004","volume":"14","author":"Z Lin","year":"2021","unstructured":"Lin Z, Vasudevan B, Liang YB, Zhou HJ, Ciuffreda KJ. The association between nearwork-induced transient myopia and progression of refractive error: a 3-year cohort report from Beijing Myopia Progression Study. J Optom. 2021;14:44\u201349.","journal-title":"J Optom"},{"key":"4534_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/opo.12049","volume":"33","author":"Z Lin","year":"2013","unstructured":"Lin Z, Vasudevan B, Liang YB, Zhang YC, Zhao SQ, Yang XD, et al. Nearwork-induced transient myopia (NITM) in anisometropia. Ophthalmic Physiol Opt. 2013;33:311\u20137.","journal-title":"Ophthalmic Physiol Opt"},{"key":"4534_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012;119:347\u201354.","journal-title":"Ophthalmology"},{"key":"4534_CR12","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","volume":"113","author":"WH Chua","year":"2006","unstructured":"Chua WH, Balakrishnan V, Chan YH, Tong L, Ling Y, Quah BL, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113:2285\u201391.","journal-title":"Ophthalmology"},{"key":"4534_CR13","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1167\/iovs.17-22562","volume":"59","author":"BJ Carr","year":"2018","unstructured":"Carr BJ, Mihara K, Ramachandran R, Saifeddine M, Nathanson NM, Stell WK, et al. Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro. Invest Ophthalmol Vis Sci. 2018;59:2778\u201391.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4534_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.exer.2007.02.019","volume":"85","author":"R Ashby","year":"2007","unstructured":"Ashby R, McCarthy CS, Maleszka R, Megaw P, Morgan IG. A muscarinic cholinergic antagonist and a dopamine agonist rapidly increase ZENK mRNA expression in the form-deprived chicken retina. Exp Eye Res. 2007;85:15\u201322.","journal-title":"Exp Eye Res"},{"key":"4534_CR15","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.1167\/iovs.11-9031","volume":"53","author":"HJ Lin","year":"2012","unstructured":"Lin HJ, Wan L, Chen WC, Lin JM, Lin CJ, Tsai FJ. Muscarinic acetylcholine receptor 3 is dominant in myopia progression. Invest Ophthalmol Vis Sci. 2012;53:6519\u201325.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4534_CR16","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1021\/pr500558y","volume":"13","author":"VA Barathi","year":"2014","unstructured":"Barathi VA, Chaurasia SS, Poidinger M, Koh SK, Tian D, Ho C, et al. Involvement of GABA transporters in atropine-treated myopic retina as revealed by iTRAQ quantitative proteomics. J Proteome Res. 2014;13:4647\u201358.","journal-title":"J Proteome Res"},{"key":"4534_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1475-1313.2012.00940.x","volume":"32","author":"P Gallego","year":"2012","unstructured":"Gallego P, Martinez-Garcia C, Perez-Merino P, Ibares-Frias L, Mayo-Iscar A, Merayo-Lloves J. Scleral changes induced by atropine in chicks as an experimental model of myopia. Ophthalmic Physiol Opt. 2012;32:478\u201384.","journal-title":"Ophthalmic Physiol Opt"},{"key":"4534_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-016-0002-7","volume":"6","author":"BJ Carr","year":"2016","unstructured":"Carr BJ, Stell WK. Nitric Oxide (NO) mediates the inhibition of form-deprivation myopia by atropine in chicks. Sci Rep. 2016;6:9.","journal-title":"Sci Rep"},{"key":"4534_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","volume":"123","author":"J Huang","year":"2016","unstructured":"Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H, et al. Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology. 2016;123:697\u2013708.","journal-title":"Ophthalmology"},{"key":"4534_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ophtha.2008.10.020","volume":"116","author":"L Tong","year":"2009","unstructured":"Tong L, Huang XL, Koh AL, Zhang X, Tan DT, Chua WH. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology. 2009;116:572\u20139.","journal-title":"Ophthalmology"},{"key":"4534_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops. Ophthalmology. 2016;123:391\u20139.","journal-title":"Ophthalmology"},{"key":"4534_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1167\/iovs.08-1762","volume":"50","author":"B Vasudevan","year":"2009","unstructured":"Vasudevan B, Ciuffreda KJ, Gilmartin B. Sympathetic inhibition of accommodation after sustained nearwork in subjects with myopia and emmetropia. Invest Ophthalmol Vis Sci. 2009;50:114\u201320.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4534_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/jop.2019.0062","volume":"36","author":"L Guo","year":"2020","unstructured":"Guo L, Fan L, Tao J, Hua R, Yang Q, Gu H, et al. Use of topical 0.01% atropine for controlling near work-induced transient myopia: a randomized, double-masked, placebo-controlled study. J Ocul Pharm Ther. 2020;36:97\u2013101.","journal-title":"J Ocul Pharm Ther"},{"key":"4534_CR24","first-page":"182","volume":"25","author":"XT Liu","year":"2023","unstructured":"Liu XT, Xu MP, Deng RY. Efficacy and safety of 0.01% sulfate atropine on reducing nearwork-induced transient myopia in children and adolescents. Chin J Optom Ophthalmol Vis Sci. 2023;25:182\u20137.","journal-title":"Chin J Optom Ophthalmol Vis Sci"},{"key":"4534_CR25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.2022.24162","volume":"329","author":"JC Yam","year":"2023","unstructured":"Yam JC, Zhang XJ, Zhang Y, Yip BHK, Tang F, Wong ES, et al. Effect of low-concentration atropine eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical Trial. JAMA. 2023;329:472\u201381.","journal-title":"JAMA"},{"key":"4534_CR26","first-page":"1797","volume":"39","author":"KJ Ciuffreda","year":"1998","unstructured":"Ciuffreda KJ, Wallis DM. Myopes show increased susceptibility to nearwork aftereffects. Invest Ophthalmol Vis Sci. 1998;39:1797\u2013803.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4534_CR27","doi-asserted-by":"publisher","first-page":"e079833","DOI":"10.1136\/bmjopen-2023-079833","volume":"13","author":"G Qin","year":"2023","unstructured":"Qin G, Chen J, Hu L, Qi Y, Xu L, He W, et al. Protocol for a parallel assignment prospective, randomised, double-blinded, placebo-controlled trial to evaluate the efficacy of 0.01% atropine for near work-induced transient myopia and myopic progression in China. BMJ Open. 2023;13:e079833.","journal-title":"BMJ Open"},{"key":"4534_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40101-024-00354-7","volume":"43","author":"S Biswas","year":"2024","unstructured":"Biswas S, El Kareh A, Qureshi M, Lee DMX, Sun CH, Lam JSH, et al. The influence of the environment and lifestyle on myopia. J Physiol Anthropol. 2024;43:7.","journal-title":"J Physiol Anthropol"},{"key":"4534_CR29","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaophthalmol.2023.2855","volume":"141","author":"MX Repka","year":"2023","unstructured":"Repka MX, Weise KK, Chandler DL, Wu R, Melia BM, Manny RE, et al. Low-dose 0.01% atropine eye drops vs placebo for myopia control: a randomized clinical trial. JAMA Ophthalmol. 2023;141:756\u201365.","journal-title":"JAMA Ophthalmol"},{"key":"4534_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, et al. Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology. 2019;126:113\u201324.","journal-title":"Ophthalmology"},{"key":"4534_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/iovs.63.3.12","volume":"63","author":"RPJ Hughes","year":"2022","unstructured":"Hughes RPJ, Read SA, Collins MJ, Vincent SJ. Axial elongation during short-term accommodation in myopic and nonmyopic children. Invest Ophthalmol Vis Sci. 2022;63:12.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04534-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04534-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04534-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:01:42Z","timestamp":1790920902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04534-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":31,"alternative-id":["4534"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04534-w","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}